Bo Sun Kang

Prof. Bo Sun Kang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in The Korean Journal of Physiology & Pharmacology
Verified
Journal Article
Open access
PDF file
SKSeong Hee Kang
Seong Hee Kang
DBDong-Ho Bak
Dong-Ho Bak
BCByung Yeoup Chung
Byung Yeoup Chung
HBHyoung-Woo Bai
Hyoung-Woo Bai
BKBo Sun Kang
Bo Sun Kang
Seong Hee Kang, Dong-Ho Bak, Byung Yeoup Chung, Hyoung-Woo Bai, and Bo Sun Kang. Korean J Physiol Pharmacol 2020;24:413-22. https://doi.org/10.4196/kjpp.2020.24.5.413

1 January 2016 in Nutrition Research and Practice
Verified
Journal Article
Open access
PDF file
SKSuk Hee Kim
Suk Hee Kim
SKSeong Hee Kang
Seong Hee Kang
BKBo Sun Kang
Bo Sun Kang
Kim SH, et al. Nutr Res Pract. 2016 Aug;10(4):393-397. http://dx.doi.org/10.4162/nrp.2016.10.4.393

18 August 2016 in Nanomaterials
Verified
Journal Article
Open access
PDF file
KYKwang Sik Yu
Kwang Sik Yu
MLMeng Meng Lin
Meng Meng Lin
HLHyunju Lee
Hyunju Lee
Ki-Sik TaeKi-Sik Tae
Ki-Sik Tae
BKBo Sun Kang
Bo Sun Kang
DKDo Kyung Kim
Do Kyung Kim
The present report proposes a more rational hyaluronic acid (HA) conjugation protocol that can be used to modify the surface of the superparamagnetic iron oxide nanoparticles (SPIONs) by covalently binding the targeting molecules (HA) with glutamic acid as a molecular linker on peripheral surface of SPIONs. The synthesis of HA-Glutamic Acid (GA)@SPIONs was included oxidization of nanoparticle’s surface with H2O2 followed by activation of hydroxyl group and reacting glutamic acid as an intermediate molecule demonstrating transfection of lung cancer cells. Fourier transform infrared (FTIR) and zeta-potential studies confirmed the chemical bonding between amino acid linker and polysaccharides. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay showed that HA-SPIONs-treated cells remained 82.9% ± 2.7% alive at high particle dosage (200 µg/mL iron concentration), whereas GA-SPIONs and bare SPIONs (B-SPIONs) treated cells had only 59.3% ± 13.4% and 26.5% ± 3.1% survival rate at the same conditions, respectively. Confocal microscopy analysis showed increased cellular internalization of HA-SPIONs compared to non-interacting agarose coated SPIONs (AgA-SPIONs).

18 April 2016 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
SHSeong-Pyo Hong
Seong-Pyo Hong
SKSeong Hee Kang
Seong Hee Kang
DKDo Kyung Kim
Do Kyung Kim
BKBo Sun Kang
Bo Sun Kang
This study aimed to synthesize theranostic agent targeting C6 rat glioma cell, which was based on the dextran coated paramagnetic gadolinium oxide nanoparticles (D-PGONs) conjugated with folic acid (FA) or paclitaxel (PTX). The D-PGONs were synthesized by thein situcoprecipitation method, and the average value of the size distribution was 2.9 nm. FTIR spectroscopy was fulfilled to confirm the conjugations of FA or PTX with D-PGONs. The bioprotective effects of dextran coating and chemotherapeutic effect of PTX in the C6 glioma cell were evaluated by the MTT assay. The differences in uptakes between the synthesized theranostic agents into C6 cells were observed by confocal laser scanning microscopy. In addition, the magnetic contrast enhancement with different concentration of the synthesized agent was compared by theT1-weighted MRI imaging. It was experimentally shown that the synthesized theranostic agent targets C6 cells due to the ligand-receptor-mediated endocytosis and provides enhancement in MR contrast depending on the concentration due to the paramagnetic property of gadolinium nanoparticle. In addition, it was shown by the results of MTT assay that the synthesized nanocomposites were more effective in reducing cell viability than bare gadolinium nanoparticles. In conclusion, it was shown that FA and PTX conjugated D-PGONs could be used as the theranostic agent with paramagnetism and chemotherapeutic property.

1 January 2018 in Nutrition Research and Practice
Verified
Journal Article
Open access
PDF file
HKHyun Mi Kim
Hyun Mi Kim
SKSuk Hee Kim
Suk Hee Kim
BKBo Sun Kang
Bo Sun Kang
Kim HM, et al. Nutr Res Pract. 2018 Feb;12(1):41-46. https://doi.org/10.4162/nrp.2018.12.1.41

27 September 2018 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
SKSeong Hee Kang
Seong Hee Kang
SHSeong Pyo Hong
Seong Pyo Hong
BKBo Sun Kang
Bo Sun Kang
Purpose: This report presents novel nanoparticle-based drug delivery system (NPDDS) aiming to targeting chemo-proton therapy (TCPT) to improve the therapeutic efficacy on brain cancer treatments. Materials and methods: A NPDDS, superparamagnetic iron oxide nanoparticles conjugated with folate and paclitaxel, was synthesized and applied to C6 brain cancer cell line that was prepared for TCPT. The characterization of NPDDS was analyzed by transmission electron microscope (TEM) and Fourier transform infrared (FTIR) spectroscopy. The uptake of NPDDS into the cytoplasm of C6 cells was observed by confocal laser scanning microscopy (CLSM). The therapeutic efficacy of proton beam was quantitatively evaluated by flow cytometry and clonogenic assay at various radiation dose. Results: NPDDS was synthesized in the uniform size distribution with a mean diameter of 5.44 ± 0.70 nm, and it showed no significant cytotoxicity at the concentration lower than 200 ng/mL. Radiosensitization enhancement factors of PTX, D-SPIONs and FA-PTX-D-SPIONs were 1.35, 1.16 and 1.52, respectively. Conclusions: It was demonstrated that TCPT improved the therapeutic efficacy of the proton beam therapy when the synthesized novel NPDDS was administrated. The improvement in therapeutic efficacy was achieved by the synergetic effect of drug delivery increased by FA, radiosensitivity increased by PTX and absorption of proton energy increased by SPIONs.